# Ocular Oncology * **Definition:** A specialized field of medicine that focuses on the diagnosis and treatment of tumors and cancers affecting the eye and surrounding structures. * **Taxonomy:** Specialties / Ocular Oncology ## News * Selected news on the topic of **Ocular Oncology**, for healthcare technology leaders * 8.8K news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 5/27/2025 | [**The specialty that feels most valued by employers**](https://www.beckershospitalreview.com/quality/hospital-physician-relationships/the-specialty-that-feels-most-valued-by-employers/) | [[Beckers Hospital Review]] | | 5/24/2025 | [**769 - Healthcare IT News**](https://www.healthcareitnews.com/news%20/84546?page=768) | [[Healthcare IT News]] | | 12/26/2024 | [**Cosmos Health Appoints Dimitrios Trafalis as Head of Oncology - FirstWord Pharma**](https://firstwordpharma.com/story/5923956) | [[FirstWord PHARMA]] | | 12/19/2024 | [**Cancer Vaccines Market to Hit USD 20.47 Billion by 2032 with 8.6AGR - MarketsandMarkets™.**](https://www.prnewswire.com/news-releases/cancer-vaccines-market-to-hit-usd-20-47-billion-by-2032-with-8-6-cagr--marketsandmarkets-302336020.html) | [[PR Newswire]] | | 12/12/2024 | [**Health IT Business News - December 12, 2024**](https://www.healthitanswers.net/health-it-business-news-december-12-2024/) | [[Health IT Answers]] | | 12/11/2024 | [**Do AI Diagnostics have a role in telemedicine? What does this mean for healthcare equity?**](https://www.healthtechmagazines.com/do-ai-diagnostics-have-a-role-in-telemedicine-what-does-this-mean-for-healthcare-equity/) | [[Health Tech Magazines]] | | 12/10/2024 | [**Beghou Consulting Adds Three Partners to Strengthen Data and Analytics Excellence and Commercialization Expertise Across Emerging Life Sciences Sectors**](https://www.prweb.com/releases/beghou-consulting-adds-three-partners-to-strengthen-data-and-analytics-excellence-and-commercialization-expertise-across-emerging-life-sciences-sectors-302326336.html) | [[PRWeb]] | | 11/15/2024 | [**Whole Genome and Exome Sequencing Markets, 2033 - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241115785002/en/Whole-Genome-and-Exome-Sequencing-Markets-2033---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 11/1/2024 | [**Xtalks Announces its Life Science Webinar Calendar for November 2024**](https://www.prweb.com/releases/xtalks-announces-its-life-science-webinar-calendar-for-november-2024-302293808.html) | [[PRWeb]] | | 11/1/2024 | [**Ferrum Health Raises $16M in Series A Funding to Unlock AI Adoption in Healthcare**](https://www.healthcareittoday.com/2024/11/01/ferrum-health-raises-16m-in-series-a-funding-to-unlock-ai-adoption-in-healthcare/) | [[Healthcare IT Today]] | | 10/29/2024 | [**Precision Medicine Global Thought Leader, Dr. Howard McLeod, Joins Cofactor Genomics ...**](https://www.businesswire.com/news/home/20241029349293/en/Precision-Medicine-Global-Thought-Leader-Dr.-Howard-McLeod-Joins-Cofactor-Genomics%E2%80%99-Advisory-Board-as-Cofactor-Brings-OncoPrism-test-to-Partnered-Hospitals) | [[Business Wire]] | | 10/29/2024 | [**Asia-Pacific Digital Diagnostics Market Analysis and Forecast, 2023-2024 & 2033: Synergetic Partnership Opportunities with Hospitals and Diagnostic Centers Fuel Opportunities - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241029232642/en/Asia-Pacific-Digital-Diagnostics-Market-Analysis-and-Forecast-2023-2024-2033-Synergetic-Partnership-Opportunities-with-Hospitals-and-Diagnostic-Centers-Fuel-Opportunities---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 10/29/2024 | [**Precision Medicine Global Thought Leader, Dr. Howard McLeod, Joins Cofactor Genomics' Advisory Board as Cofactor Brings OncoPrism test to Partnered Hospitals**](http://www.businesswire.com/news/home/20241029349293/en/Precision-Medicine-Global-Thought-Leader-Dr.-Howard-McLeod-Joins-Cofactor-Genomics%E2%80%99-Advisory-Board-as-Cofactor-Brings-OncoPrism-test-to-Partnered-Hospitals/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 10/22/2024 | [**HLTH: Avandra Launches World's Largest Federated Network for Medical Imaging and Clinical Data**](https://hitconsultant.net/2024/10/22/avandra-launches-worlds-largest-federated-network-for-medical-imaging-and-clinical-data/) | [[HIT Consultant]] | | 10/16/2024 | [**FDA strengthens AI regulation to ensure patient safety and innovation in healthcare**](https://www.news-medical.net/news/20241016/FDA-strengthens-AI-regulation-to-ensure-patient-safety-and-innovation-in-healthcare.aspx) | [[News Medical Net]] | | 10/9/2024 | [**Look Who's Talking at HLTH - MedCity News**](https://medcitynews.com/2024/10/look-whos-talking-at-hlth/) | [[MedCity News]] | | 10/4/2024 | [**Hyper-Personalized Medicine Market Research 2024: Size, Trends, Opportunities and Forecast 2020-2024 & 2025-2030 - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241004930872/en/Hyper-Personalized-Medicine-Market-Research-2024-Size-Trends-Opportunities-and-Forecast-2020-2024-2025-2030---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 9/23/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2823929) | [[JAMA Network]] | | 9/4/2024 | [**Viz.ai and ALCMI Partner to Unite AI and Lung Cancer Research Communities**](https://www.businesswire.com/news/siliconvalley/20240904868268/en) | [[Business Wire]] | | 9/2/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2823031) | [[JAMA Network]] | | 9/1/2024 | [**Xtalks Announces its Life Science Webinar Calendar for September 2024**](https://www.prweb.com/releases/xtalks-announces-its-life-science-webinar-calendar-for-september-2024-302235364.html) | [[PRWeb]] | | 8/26/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2822727) | [[JAMA Network]] | | 8/12/2024 | [**Quantum Health Appoints Dr. Stanley Crittenden as New Chief Medical Officer**](http://www.businesswire.com/news/home/20240812304065/en/Quantum-Health-Appoints-Dr.-Stanley-Crittenden-as-New-Chief-Medical-Officer/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 8/12/2024 | [**Audio Highlights**](https://jamanetwork.com/journals/jama/fullarticle/2822137) | [[JAMA Network]] | | 6/25/2024 | [**BioAI and Genomic Testing Cooperative Announce Strategic Collaboration to Provide AI-Powered Digital Pathology Solutions for Clinical Research and Diagnostic Applications**](https://www.prnewswire.com/news-releases/bioai-and-genomic-testing-cooperative-announce-strategic-collaboration-to-provide-ai-powered-digital-pathology-solutions-for-clinical-research-and-diagnostic-applications-302181005.html) | [[PR Newswire]] | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **Opthea Limited**: A clinical-stage biopharmaceutical company focused on developing novel therapies for retinal diseases, including wet age-related macular degeneration. - **Ontada**: Utilizes AI and natural language processing to enhance oncology data analysis and clinical decision-making. - **EDETEK Inc.**: Developed CONFORM™ ONCO+, an AI-driven accelerator for oncology clinical trials. - **Viz.ai**: A healthcare technology company specializing in AI-powered solutions for early detection and treatment coordination in oncology. - **ConcertAI**: A company providing advanced analytics and software solutions for oncology research. - **NeoGenomics**: A provider of cancer-focused genetic testing and diagnostics. - **Genoks**: A Turkish genomics healthcare company enhancing cancer diagnostics through partnerships. - **Addario Lung Cancer Medical Institute (ALCMI)**: An organization focused on lung cancer research and improving patient outcomes through collaborative efforts. - **Professor Dimitrios Trafalis**: A distinguished academic in pharmacology and clinical pharmacology specializing in oncology-hematology and personalized cancer therapies, leading research initiatives at Cosmos Health. - **Azra AI**: A healthtech firm revolutionizing oncology care through AI-driven solutions. - **AstraZeneca**: A pharmaceutical company focused on oncology, reporting successful outcomes in clinical trials for breast cancer drugs. - **Myriad Genetics**: A company focusing on innovation in oncology and women's health with significant investments. - **PreciseDx**: An innovative company in oncology diagnostics that utilizes AI for morphology-driven disease analysis to improve cancer diagnosis and prognosis. - **Velsera**: A global healthcare technology firm collaborating with Genoks to improve cancer diagnostics. - **AffyImmune Therapeutics**: A biotech firm specializing in CAR T cell therapy for solid tumors. - **Flatiron Health**: A company leveraging real-world data to enhance cancer care, collaborating with Lifebit Biotech to improve oncology data access. - **King Faisal Specialist Hospital & Research Centre (KFSHRC)**: A leading healthcare institution in Saudi Arabia, advancing oncology through AI and robotic surgeries. ### Partnerships and Collaborations - **Owkin and DACH Region Institutions**: Owkin has partnered with nine leading medical institutions in Germany, Austria, and Switzerland to enhance research capabilities in oncology. - **Genoks and Velsera**: Collaborating to integrate Clinical Genomics Workspace into cancer diagnostic services. - **Cofactor Genomics and Dr. Howard McLeod**: Appointment of a precision medicine expert to enhance the OncoPrism test. - **Cosmos Health and Professor Trafalis**: Cosmos Health appointed Professor Trafalis to lead oncology research initiatives, enhancing their commitment to innovative cancer therapies. - **Ontada and Microsoft**: Collaboration to leverage Azure AI for processing unstructured oncology documents, enhancing data extraction capabilities. - **Flatiron Health and Lifebit Biotech**: This partnership aims to enhance cancer care through secure access to real-world oncology data for research purposes. - **Azra AI and MultiCare Health System**: Partnership to implement an oncology platform aimed at enhancing patient care and operational efficiency. - **Viz.ai and ALCMI**: This partnership aims to enhance early detection and treatment of lung cancer through AI technology and improved clinical workflows, integrating patient engagement and research expertise. - **Keck School of Medicine and Ryght Research Network**: This collaboration focuses on improving clinical trial efficiency through AI technology. - **BioAI and Genomic Testing Cooperative**: A collaboration to enhance biomarker discovery and diagnostics using multimodal AI, focusing on genomic profiling for cancer. - **Novotech and Beijing Biostar Pharmaceuticals**: A strategic partnership to enhance clinical research and support Biostar's oncology development plans. - **Sonrai Analytics and Massachusetts General Hospital**: Collaborating to implement AI technology for enhanced data integration in therapeutic development. - **ConcertAI and NeoGenomics**: Launched CTO-H, a software-as-a-service solution for hematological diseases, enhancing clinical research. - **Texas Medical Center and Mitsui Fudosan Co.**: Signed a Memorandum of Understanding for the TMC Japan BioBridge to enhance cancer treatment collaboration. - **Massive Bio and Foundation Medicine**: A strategic collaboration to increase patient access to clinical trials through AI-driven patient matching. - **Carta Healthcare and Realyze Intelligence**: Acquisition aimed at improving patient matching for clinical trials. - **MetaPhy Health and ActiumHealth**: Partnered to enhance patient engagement through AI-powered voice agents. - **AQEMIA and Sanofi**: AQEMIA has a $140 million collaboration with Sanofi to support its drug discovery platform, particularly in oncology. - **Innovent Biologics and WeComput**: A strategic partnership aimed at enhancing AI for drug discovery, improving computational efficiency, and reducing costs in the drug R&D cycle. ### Innovations, Trends, and Initiatives - **Oculomics**: A field exploring the implications of eye care on systemic health, particularly in cardiovascular risk. - **Personalized Medicine**: The trend towards personalized medicine in ocular oncology is improving treatment outcomes by tailoring interventions based on individual patient factors. - **AI in Ocular Oncology**: Artificial Intelligence is transforming diagnostics in ocular oncology by analyzing large datasets to detect diseases earlier and improve treatment outcomes. - **Advancements in Imaging Technologies**: Technologies like Optical Coherence Tomography (OCT) are providing high-resolution images for precise visualization and monitoring of eye conditions. - **AI-Driven Solutions**: Increasing adoption of AI for patient monitoring and telehealth services in optometry. - **AI in Oncology**: Artificial Intelligence is transforming oncology practices, facilitating early screening and personalized treatment plans. - **Hyper-personalized Medicine**: An emerging trend focusing on tailoring treatments based on individual genetic and lifestyle factors, particularly in oncology. - **Patient-Centric Care Models**: Mass General Brigham Cancer Center's new integrative cancer care model emphasizes equity in screening and holistic patient care. - **Gold Nanoparticles in Diagnostics**: Emerging technology for effective tumor monitoring and understanding drug effectiveness. - **Federated Data Networks**: The launch of platforms like Avandra to organize medical imaging and clinical data for research and innovation in oncology. - **Next Generation Cancer Diagnostics (NGCD)**: Utilizes technologies like liquid biopsy and next-generation sequencing to improve cancer diagnostics. - **AI-Enabled Health Record Insights**: New research indicates that combining AI insights with educational interventions can improve management of adverse events in oncology, exemplified by Project EVOLVE. - **Real-World Evidence**: Flatiron Health's focus on real-world data is crucial for understanding treatment outcomes and improving patient care in oncology. - **3D Diagnostic Imaging Services**: Growth driven by AI, machine learning, and big data analytics to improve patient outcomes. - **Decentralized Clinical Trials (DCTs)**: Emerging trend enhancing participant recruitment and retention through remote participation. - **Virtual Clinical Trials**: Rapid growth due to digital health technologies, enhancing accessibility for chronic conditions. - **BD OMICS-One XT WTA Assay**: A high-throughput reagent kit designed to enhance DNA library preparation for single-cell studies. ### Challenges and Concerns - **Oncology Care Challenges**: Concerns regarding the end of the Oncology Care Model and potential reimbursement cuts due to drug price negotiations. - **Data Management in Clinical Trials**: The need for improved data quality and compliance in oncology clinical trials, addressed by innovations like CONFORM™ ONCO+. - **Low Clinical Trial Enrollment**: Only about 8% of eligible patients participate in oncology clinical trials, highlighting the need for improved patient matching and access. - **Healthcare Access Disparities**: Challenges such as an aging population and disparities in healthcare access necessitate collaboration among providers to enhance eye care delivery. - **Data Privacy and Governance**: As partnerships expand to utilize real-world data, ensuring data privacy and governance remains a critical concern in oncology research. - **Technology Overload**: Community oncology practices face challenges in adopting new technologies due to limited resources and expertise, leading to fragmented systems. - **Clinical Trial Inefficiencies**: The clinical trial landscape faces significant inefficiencies, including high staff turnover and administrative burdens, which partnerships like that of Keck School of Medicine and Ryght aim to address. - **Data Security in AI Applications**: Concerns regarding data security in AI-driven diagnostics and treatment plans are prevalent, influencing the adoption of on-premise delivery modes. - **Staffing Shortages**: Ambulatory Surgery Centers (ASCs) face challenges in staffing, impacting operational efficiency. - **AI Adoption in Healthcare**: Despite significant investments in clinical AI startups, healthcare AI adoption remains low at 5%, indicating challenges in integration and acceptance. - **Sales and Partnership Challenges**: Flatiron Health has faced difficulties in sales and partnerships due to concerns from other drugmakers regarding its ownership by Roche. - **Quality of Care Gaps**: Concerns about potential gaps in care quality and delivery impacting patient outcomes, particularly in community settings. - **Regulatory Hurdles in DCTs**: Challenges related to regulatory compliance and data privacy in decentralized clinical trials. - **Healthcare Equity**: Despite AI's potential, challenges remain regarding reimbursement models and clinician burnout. - **Environmental Concerns**: Issues related to waste management and recycling of disposable medical supplies. - **Market Competition**: Increased competition in the healthcare technology sector may impact profitability. - **Data Security and Privacy**: The need for effective cybersecurity measures to protect patient data in the context of increasing digital health solutions. - **Trustworthy AI Models**: Need for reliable AI models in assessing cardiovascular risk factors before clinical adoption. - **Regulatory Landscape**: Startups face challenges in navigating complex regulatory requirements. ## Related Topics [[Ophthalmology]]; [[Oncology]]; [[Surgical Oncology]]; [[Neuro-Ophthalmology]]; [[Gynecologic Oncology]]